BR112022019752A2 - Síntese de oligonucleotídeos e compostos relacionados - Google Patents

Síntese de oligonucleotídeos e compostos relacionados

Info

Publication number
BR112022019752A2
BR112022019752A2 BR112022019752A BR112022019752A BR112022019752A2 BR 112022019752 A2 BR112022019752 A2 BR 112022019752A2 BR 112022019752 A BR112022019752 A BR 112022019752A BR 112022019752 A BR112022019752 A BR 112022019752A BR 112022019752 A2 BR112022019752 A2 BR 112022019752A2
Authority
BR
Brazil
Prior art keywords
support
synthesis
azidomethyl
moiety
oligonucleotide
Prior art date
Application number
BR112022019752A
Other languages
English (en)
Portuguese (pt)
Inventor
Zhong Minghong
Jin Yi
Gala Dinesh
Prhavc Marija
Original Assignee
Janssen Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biopharma Inc filed Critical Janssen Biopharma Inc
Publication of BR112022019752A2 publication Critical patent/BR112022019752A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
BR112022019752A 2020-03-31 2021-03-30 Síntese de oligonucleotídeos e compostos relacionados BR112022019752A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063003067P 2020-03-31 2020-03-31
PCT/IB2021/052595 WO2021198883A1 (en) 2020-03-31 2021-03-30 Synthesis of oligonucleotides and related compounds

Publications (1)

Publication Number Publication Date
BR112022019752A2 true BR112022019752A2 (pt) 2022-11-16

Family

ID=75340013

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022019752A BR112022019752A2 (pt) 2020-03-31 2021-03-30 Síntese de oligonucleotídeos e compostos relacionados

Country Status (11)

Country Link
US (1) US12649761B2 (enExample)
EP (1) EP4126894A1 (enExample)
JP (1) JP2023520201A (enExample)
KR (1) KR20220161436A (enExample)
CN (1) CN115843299A (enExample)
AU (1) AU2021247043A1 (enExample)
BR (1) BR112022019752A2 (enExample)
CA (1) CA3178892A1 (enExample)
IL (1) IL296862A (enExample)
MX (1) MX2022012255A (enExample)
WO (1) WO2021198883A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12649761B2 (en) 2020-03-31 2026-06-09 Janssen Biopharma, Inc. Synthesis of oligonucleotides and related compounds
CN116888136A (zh) 2021-02-12 2023-10-13 味之素株式会社 寡核苷酸的制备方法
EP4601656A1 (en) * 2022-10-12 2025-08-20 Pharmorage Pty Limited Modified oligonucleotides
EP4755898A1 (en) 2023-08-02 2026-06-10 Nitto Denko Corporation Method for producing oligonucleotide
WO2025235761A1 (en) * 2024-05-09 2025-11-13 Biogen Ma Inc. Reagents and processes for preparing oligonucleotides

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001704A1 (en) 1990-07-26 1992-02-06 Koichi Shudo Oligodeoxyribonucleotides
US6972330B2 (en) * 1996-02-13 2005-12-06 Sirna Therapeutics, Inc. Chemical synthesis of methoxy nucleosides
US5753789A (en) 1996-07-26 1998-05-19 Yale University Oligonucleotides containing L-nucleosides
ES2192672T3 (es) 1996-11-18 2003-10-16 Takeshi Imanishi Nuevos analogos de nucleotidos.
US6770748B2 (en) 1997-03-07 2004-08-03 Takeshi Imanishi Bicyclonucleoside and oligonucleotide analogue
JP3756313B2 (ja) 1997-03-07 2006-03-15 武 今西 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
US6251666B1 (en) 1997-03-31 2001-06-26 Ribozyme Pharmaceuticals, Inc. Nucleic acid catalysts comprising L-nucleotide analogs
US6794499B2 (en) 1997-09-12 2004-09-21 Exiqon A/S Oligonucleotide analogues
EP1015469B2 (en) 1997-09-12 2015-11-18 Exiqon A/S Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
BRPI0008131B8 (pt) 1999-02-12 2021-05-25 Daiichi Sankyo Co Ltd composto ou um sal deste, análogo de oligonucleotídeo, composição farmacêutica, sonda para um gene,iniciador para começar a amplificação, uso de um análogo de oligonucleotídeo ou de um sal deste farmacologicamente aceitável, agente antisentido, e, agente antígeno
JP2000247940A (ja) * 1999-02-26 2000-09-12 Sankyo Co Ltd 新規ベンジルアジド化合物
US7084125B2 (en) 1999-03-18 2006-08-01 Exiqon A/S Xylo-LNA analogues
ATE356824T1 (de) 1999-05-04 2007-04-15 Santaris Pharma As L-ribo-lna analoge
US6525191B1 (en) 1999-05-11 2003-02-25 Kanda S. Ramasamy Conformationally constrained L-nucleosides
JP4151751B2 (ja) 1999-07-22 2008-09-17 第一三共株式会社 新規ビシクロヌクレオシド類縁体
US7569575B2 (en) 2002-05-08 2009-08-04 Santaris Pharma A/S Synthesis of locked nucleic acid derivatives
CA2504694C (en) 2002-11-05 2013-10-01 Isis Pharmaceuticals, Inc. Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
CN101684136A (zh) * 2008-09-23 2010-03-31 苏州瑞博生物技术有限公司 一种寡核苷酸的制备方法
WO2013179412A1 (ja) 2012-05-30 2013-12-05 北海道システム・サイエンス株式会社 高分散性液相支持体を用いたオリゴヌクレオチド合成法
US10214555B2 (en) 2012-11-14 2019-02-26 Takeda Pharmaceutical Company Limitjed Method for liquid-phase synthesis of nucleic acid
EP3398955B1 (en) 2015-12-16 2026-06-03 Ajinomoto Co., Inc. Oligonucleotide production method, and nucleoside, nucleotide, or oligonucleotide
JPWO2017111137A1 (ja) 2015-12-22 2018-10-18 味の素株式会社 オリゴヌクレオチドの製造方法
JP7306263B2 (ja) 2017-05-02 2023-07-11 日産化学株式会社 オリゴヌクレオチドの製造方法
US12649761B2 (en) 2020-03-31 2026-06-09 Janssen Biopharma, Inc. Synthesis of oligonucleotides and related compounds

Also Published As

Publication number Publication date
KR20220161436A (ko) 2022-12-06
AU2021247043A1 (en) 2022-10-27
US12649761B2 (en) 2026-06-09
MX2022012255A (es) 2023-01-11
CN115843299A (zh) 2023-03-24
EP4126894A1 (en) 2023-02-08
IL296862A (en) 2022-11-01
CA3178892A1 (en) 2021-10-07
JP2023520201A (ja) 2023-05-16
US20240092821A1 (en) 2024-03-21
WO2021198883A1 (en) 2021-10-07

Similar Documents

Publication Publication Date Title
MX2022012255A (es) Sintesis de oligonucleotidos y compuestos relacionados.
Tolnai et al. Efficient O‐functionalization of carbohydrates with electrophilic reagents
CA3029320C (en) Nucleic acid synthesis and sequencing using tethered nucleoside triphosphates
PT98489A (pt) Processo para a producao de um grande polinucleotido ramificado do tipo combinado
Vaníková et al. Polymerase synthesis of photocaged DNA resistant against cleavage by restriction endonucleases
BR9801878A (pt) Iniciadores de amplificação de ácido nucleìco modificado
BR112022026056A2 (pt) Nucleosídeos e nucleotídeos com grupo bloqueador 3? acetal
AU2016349457A1 (en) Nucleotide analogues
Samanta et al. A modified dinucleotide for site-specific RNA-labelling by transcription priming and click chemistry
DK0408295T3 (da) Fremgangsmåder til opformering af nukleinsyresekvenser
ATE460499T1 (de) Reiterative oligonukleotidsynthese nutzende molekulare nachweissysteme
EP1874792A4 (en) ACTIVATORS FOR THE OLIGONUCLEOTIDE AND PHOSPHORAMIDITE SYNTHESIS
BRPI0413309B8 (pt) método para a preparação de uma vacina conjugada de polissacarídeo-proteína
Tamura et al. A novel method for sulfilimines and sulfoximines
JP2018123133A (ja) 組成物及びオリゴヌクレオチドをコンジュゲートする方法
CN105001292A (zh) 一种光可断裂的荧光标记可逆终端化合物及其在dna或rna测序中的用途
Smith et al. Spatially selective electrochemical cleavage of a polymerase-nucleotide conjugate
MX2009008081A (es) Generacion de moleculas de acido nucleico.
WO2020206114A1 (en) Sequencing by synthesis with energy transfer dye pairs
Suchsland et al. Preparation of trinucleotide phosphoramidites as synthons for the synthesis of gene libraries
Hollenstein et al. Polymerase incorporation of pyrene-nucleoside triphosphates
Maine et al. The antitumor agent CC-1065 inhibits helicase-catalyzed unwinding of duplex DNA
Depaix et al. One‐pot synthesis of nucleotides and conjugates in aqueous medium
NO972868L (no) Oligonukleotid-dendrimer konjugater
Inoue et al. Efficient site-specific cleavage of RNA using a terpyridine–copper (II) complex joined to a 2′-O-methyloligonucleotide by a non-flexible linker

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2873 DE 27-01-2026 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.